Fundz

Melt Pharmaceuticals reported raising $39.5 Million in an initial SEC Form D filing, from an offering of $30 Million

RECENTLY ACQUIREDAug 11, 2023

Amount Raised

$39.5 Million

$39.5 Million sold, per SEC Form D (first sale Jul 28, 2023)

Round Type

Seed

BrentwoodManufacturingHealthcareHealth Care

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as Melt Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Mixlab raised $10M (Series A) on August 14, 2023.
  • Tenon Medical raised $287K (Seed) on July 24, 2023.
  • RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
  • Talphera, Inc. raised $10M on July 17, 2023.
  • CurvaFix raised $39M (Series C) on July 14, 2023.
  • CurvaFix raised $24M on June 29, 2023.

Who to call at Melt Pharmaceuticals, and when

A new round usually means Melt Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Melt Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Melt Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Melt Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Melt Pharmaceuticals

Location

6 CADILLAC DRIVE

Brentwood, Tennessee, United States

About

Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non-intravenous and non-opioid sedation and analgesia medicines for short-duration medical procedures in outpatient and in-office settings. Melt’s core technology is a series of combination non-opioid sedation drug formulations that may replace or supplement current sedation modalities for more than 100 million medical procedures in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Melt Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Melt Pharmaceuticals. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Melt Pharmaceuticals's next move

See what Strategic adds

Melt Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.